An online school of Anesthetists and Resuscitators Federation (PAR) was held on July 4, 2020, in the form of a training seminar. Practitioners from the medical community dedicated their reports to infectious diseases: COVID-19, sepsis, and nosocomial pneumonia.
Although the pandemic spread across the globe yesterday a few months ago, we can observe positive statistics on the number of recovered. Yet, medicine is faced with a poorly studied aggressive virus. The webinar participants shared their gained expertise - this is what is the primary value when, in one place, medical workers can hear colleagues’ experience, analyze it, and implement it in their work.
The first speaker was V.V. Kulabukhov, Leading Researcher of GBUZ Research Institute of Ambulance, named after N.V. Sklifosovsky, Ph.D., docent. As you know, one of the hardest complications from the current COVID-19 is sepsis. Vladimir Vitalyevich spoke about present problems of sepsis, considered ways to solve this problem, raised epidemiology issues in general, as well as the questions of diagnosis and treatment. He also offered specific steps to combat sepsis for the medical community.
One of the definitions of sepsis reads: sepsis is a pathological process based on the body’s reaction in the form of systemic inflammation to an infection of different nature (bacterial, viral, fungal) in combination with acute signs of organ dysfunction or evidence of microbial dissemination.
According to statistics Global Sepsis Alliance sepsis prevalence in the world is 30 million cases a year, about 6 million people die annually. However, only in 2017, did the WHO Assembly in Geneva recognize sepsis as a global problem.
In his report, Vladimir Vitalyevich, in detail, shared his experience in the fight against sepsis. He also gave an example of a review of applied solutions for extracorporeal blood purification. He highlighted a unique bimodal sorption mechanism of Efferon-LPS. This column makes it possible to fight sepsis of the alleged gram-negative etiology, septic shock, critical endotoxemia, and ischemia syndrome-reperfusion.
Since March 2020, NANOLEK has been actively engaged in sorption techniques in Russia and presents unique Russian solutions Efferon-LPS and Efferon-CT. The columns’ production has been based on MSU Science Park and Cluster of Biomedical Technologies of the Skolkovo Foundation.